Pergolide restores sleep maintenance but impairs sleep EEG synchronization in patients with restless legs syndrome

Sleep Medicine

Volumn 3, Issue 1, 2002, Pages 49-54

  Tagaya, Hirokuni ^a   Wetter, Thomas C ^a   Winkelmann, Juliane ^a   Rubin, Marina ^b   Hundemer, Hans Peter ^b   Trenkwalder, Claudia ^a   Friess, Elisabeth ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^b LILLY DEUTSCHLAND GMBH   (Germany)

Author keywords

Dopamine agonist; EEG synchronization; Pergolide; Restless legs syndrome; Spectral analysis

Indexed keywords

ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; CARBAMAZEPINE; DOMPERIDONE; DOPAMINE RECEPTOR STIMULATING AGENT; LEVODOPA; NEUROLEPTIC AGENT; OPIATE; PERGOLIDE; PLACEBO;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICAL SYNCHRONIZATION; CROSSOVER PROCEDURE; DELTA RHYTHM; DOPAMINERGIC ACTIVITY; DOUBLE BLIND PROCEDURE; DRUG EFFECT; ELECTROENCEPHALOGRAM; FEMALE; HUMAN; MALE; NONREM SLEEP; POLYSOMNOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REM SLEEP; RESTLESS LEGS SYNDROME; SCORING SYSTEM; SIDE EFFECT; SLEEP DISORDER; SLEEP PATTERN; SLEEP STAGE; VISUAL ANALOG SCALE; WAKEFULNESS;

EID: 0036179047     PISSN: 13899457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1389-9457(01)00116-2     Document Type: Article

References (33)

1. Circadian rhythm of periodic limb movements and sensory symptoms of restless legs syndrome
2. Randomized, double-blind, placebo-controlled trial of pergolide in restless legs syndrome
3. Treatment of restless legs syndrome with pergolide: An open clinical trial
4. A randomized controlled study of pergolide in patients with restless legs syndrome
5. The treatment of restless legs syndrome and periodic limb movement disorder. An American Academy of Sleep Medicine review
6. Restless legs syndrome improved by pramipexole - A double-blind randomized trial
7. Ropinirole for restless legs syndrome
8. Treatment of periodic leg movement disorder and restless leg syndrome with talipexole
9. Pergolide: A review of its pharmacological properties and therapeutic potentials in Parkinson's disease
10. Pergolide in the management of restless legs syndrome: An extended study
11. REM inhibitory effect of L-Dopa infusion during human sleep
12. Suppression of REM and delta sleep by apomorphine in man: A dopamine mimetic effect
13. A manual of standardized terminology, techniques and scoring system for sleep stages of human subjects
14. Clinical, polysomnographic, and genetic characteristics of restless legs syndrome: A study of 133 patients diagnosed with new standard criteria
15. Dehydroepiandrosterone increases rapid-eye-movement sleep and EEG power in the spindle-frequency range
16. Aetiology and treatment of restless legs syndrome
17. Dynamics of slow-wave activity and spindle frequency activity in the human sleep EEG: Effect of midazolam and zopiclone
18. Restless legs syndrome and nocturnal myoclonus
19. Cerebral generators involved in the pathogenesis of the restless legs syndrome
20. Rapid eye movement sleep behavior disorder preceding Parkinson's disease with therapeutic response to levodopa
21. The dopamine D1 receptor agonists. A68930 and SKF 38393, induce arousal and suppress REM sleep in the rat
22. Effects of a D2 receptor agonist RO 41-9067 alone and with clonidine on sleep parameters in the rat
23. Effects of the D3 preferring dopamine agonist pramipexole on sleep and waking, locomotor activity and striatal dopamine release
24. Behavioural and ECoG spectrum power effects after intraventricular injection of drugs altering dopaminergic transmission in rats
25. Biphasic effects of dopamine D-2 receptor agonists on sleep and wakefulness in the rat
26. Thalamocortical oscillations in the sleeping and aroused brain
27. Dopamine-containing systems in the CNS
28. 125I]epidepride
29. Dopamine modulates the responsivity of mediodorsal thalamic cells in vitro
30. Immunohistochemical localization of the D1 dopamine receptor in rat brain reveals its axonal transport, pre- and postsynaptic localization, and prevalence in the basal ganglia, limbic system, and thalamic reticular nucleus
31. Ventral tegmental area: Site through which dopamine D2-receptor agonists evoke behavioral and electrocortical sleep in rats
32. Movement disorders specific to sleep and the nocturnal manifestations of waking movement disorders
33. Treatment of periodic leg movements with a dopaminergic agonist in subjects with total spinal cord lesions